Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15


Automated Flow Cytometric MRD Assessment in Childhood Acute B- Lymphoblastic Leukemia Using Supervised Machine Learning.

Reiter M, Diem M, Schumich A, Maurer-Granofszky M, Karawajew L, Rossi JG, Ratei R, Groeneveld-Krentz S, Sajaroff EO, Suhendra S, Kampel M, Dworzak MN; International Berlin-Frankfurt-Münster (iBFM)-FLOW-network and the AutoFLOW consortium.

Cytometry A. 2019 Jul 7. doi: 10.1002/cyto.a.23852. [Epub ahead of print]


CD371 cell surface expression: a unique feature of DUX4-rearranged acute lymphoblastic leukemia.

Schumich A, Zaliova M, Fortschegger K, Nebral K, Attarbaschi A, Fiser K, Kauer MO, Popitsch N, Haslinger S, Inthal A, Buldini B, Basso G, Bourquin JP, Gaipa G, Brüggemann M, Feuerstein T, Maurer-Granofszky M, Panzer-Grümayer R, Trka J, Mann G, Haas OA, Hrusak O, Dworzak MN, Strehl S.

Haematologica. 2019 Aug;104(8):e352-e355. doi: 10.3324/haematol.2018.214353. Epub 2019 Jan 31. No abstract available.


Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000.

Schumich A, Maurer-Granofszky M, Attarbaschi A, Pötschger U, Buldini B, Gaipa G, Karawajew L, Printz D, Ratei R, Conter V, Schrappe M, Mann G, Basso G, Dworzak MN; AIEOP-BFM-ALL-FLOW-Study Group.

Pediatr Blood Cancer. 2019 May;66(5):e27590. doi: 10.1002/pbc.27590. Epub 2018 Dec 18.


Concurrent Acute Myelofibrosis and Acute Lymphoblastic Leukemia in Childhood: Case Report and Review of the Literature.

Friesenbichler W, Schumich A, Simonitsch-Klupp I, Panzer-Grümayer R, Haas O, Mann G, Dworzak M.

J Pediatr Hematol Oncol. 2018 Apr;40(3):235-237. doi: 10.1097/MPH.0000000000000993. Review.


AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia.

Dworzak MN, Buldini B, Gaipa G, Ratei R, Hrusak O, Luria D, Rosenthal E, Bourquin JP, Sartor M, Schumich A, Karawajew L, Mejstrikova E, Maglia O, Mann G, Ludwig WD, Biondi A, Schrappe M, Basso G; International-BFM-FLOW-network.

Cytometry B Clin Cytom. 2018 Jan;94(1):82-93. doi: 10.1002/cyto.b.21518. Epub 2017 Feb 21.


Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.

Boztug H, Schumich A, Pötschger U, Mühlegger N, Kolenova A, Reinhardt K, Dworzak M.

Cytometry B Clin Cytom. 2013 Nov-Dec;84(6):370-8. doi: 10.1002/cyto.b.21082. Epub 2013 Feb 28.


Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia.

Gaipa G, Cazzaniga G, Valsecchi MG, Panzer-Grümayer R, Buldini B, Silvestri D, Karawajew L, Maglia O, Ratei R, Benetello A, Sala S, Schumich A, Schrauder A, Villa T, Veltroni M, Ludwig WD, Conter V, Schrappe M, Biondi A, Dworzak MN, Basso G.

Haematologica. 2012 Oct;97(10):1582-93. doi: 10.3324/haematol.2011.060426. Epub 2012 May 11.


Detection and monitoring of normal and leukemic cell populations with hierarchical clustering of flow cytometry data.

Fišer K, Sieger T, Schumich A, Wood B, Irving J, Mejstříková E, Dworzak MN.

Cytometry A. 2012 Jan;81(1):25-34. doi: 10.1002/cyto.a.21148. Epub 2011 Oct 11.


Death induction by CD99 ligation in TEL/AML1-positive acute lymphoblastic leukemia and normal B cell precursors.

Husak Z, Printz D, Schumich A, Pötschger U, Dworzak MN.

J Leukoc Biol. 2010 Aug;88(2):405-12. doi: 10.1189/jlb.0210097. Epub 2010 May 7.


Modulation of antigen expression in B-cell precursor acute lymphoblastic leukemia during induction therapy is partly transient: evidence for a drug-induced regulatory phenomenon. Results of the AIEOP-BFM-ALL-FLOW-MRD-Study Group.

Dworzak MN, Gaipa G, Schumich A, Maglia O, Ratei R, Veltroni M, Husak Z, Basso G, Karawajew L, Gadner H, Biondi A.

Cytometry B Clin Cytom. 2010 May;78(3):147-53. doi: 10.1002/cyto.b.20516.


CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy.

Dworzak MN, Schumich A, Printz D, Pötschger U, Husak Z, Attarbaschi A, Basso G, Gaipa G, Ratei R, Mann G, Gadner H.

Blood. 2008 Nov 15;112(10):3982-8. doi: 10.1182/blood-2008-06-164129. Epub 2008 Sep 9.


Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible.

Dworzak MN, Gaipa G, Ratei R, Veltroni M, Schumich A, Maglia O, Karawajew L, Benetello A, Pötschger U, Husak Z, Gadner H, Biondi A, Ludwig WD, Basso G.

Cytometry B Clin Cytom. 2008 Nov;74(6):331-40. doi: 10.1002/cyto.b.20430.


Prednisone induces immunophenotypic modulation of CD10 and CD34 in nonapoptotic B-cell precursor acute lymphoblastic leukemia cells.

Gaipa G, Basso G, Aliprandi S, Migliavacca M, Vallinoto C, Maglia O, Faini A, Veltroni M, Husak D, Schumich A, Ratei R, Biondi A, Dworzak MN; I-BFM-ALL-FCM-MRD-Study Group.

Cytometry B Clin Cytom. 2008 May;74(3):150-5. doi: 10.1002/cyto.b.20408.


CD44 deficiency is a consistent finding in childhood Burkitt's lymphoma and leukemia.

Attarbaschi A, Mann G, Schumich A, König M, Pickl WF, Haas OA, Gadner H, Dworzak MN.

Leukemia. 2007 May;21(5):1110-3. Epub 2007 Mar 1. No abstract available.


Initial human myeloid/dendritic cell progenitors identified by absence of myeloperoxidase protein expression.

Scholz W, Platzer B, Schumich A, Höcher B, Fritsch G, Knapp W, Strobl H.

Exp Hematol. 2004 Mar;32(3):270-6.


Supplemental Content

Loading ...
Support Center